Cargando…
Autologous Mesenchymal Stem Cells in Chronic Stroke
BACKGROUND: Cell transplantation is a ‘hype and hope’ in the current scenario. It is in the early stage of development with promises to restore function in chronic diseases. Mesenchymal stem cell (MSC) transplantation in stroke patients has shown significant improvement by reducing clinical and func...
Autores principales: | Bhasin, Ashu, Srivastava, M.V. Padma, Kumaran, S. Senthil, Mohanty, Sujata, Bhatia, Rohit, Bose, Sushmita, Gaikwad, Shailesh, Garg, Ajay, Airan, Balram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343764/ https://www.ncbi.nlm.nih.gov/pubmed/22566987 http://dx.doi.org/10.1159/000333381 |
Ejemplares similares
-
Safety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow up
por: Bhasin, Ashu, et al.
Publicado: (2017) -
Paracrine Mechanisms of Intravenous Bone Marrow-Derived Mononuclear Stem Cells in Chronic Ischemic Stroke
por: Bhasin, Ashu, et al.
Publicado: (2016) -
Autologous Intravenous Mononuclear Stem Cell Therapy in Chronic Ischemic Stroke
por: Bhasin, A, et al.
Publicado: (2012) -
Fibroblast Growth Factor-2 alone as an efficient inducer for differentiation of human bone marrow mesenchymal stem cells into dopaminergic neurons
por: Nandy, Sushmita Bose, et al.
Publicado: (2014) -
Hair & skin derived progenitor cells: In search of a candidate cell for regenerative medicine
por: Kumar, Anil, et al.
Publicado: (2016)